{"id":42852,"date":"2025-10-29T16:16:32","date_gmt":"2025-10-29T10:46:32","guid":{"rendered":"https:\/\/dailynewsindia.co.in\/index.php\/2025\/10\/29\/fischer-medical-ventures-reports-123-percent-yoy-surge-in-total-income-for-q2-fy26\/"},"modified":"2025-10-29T16:16:32","modified_gmt":"2025-10-29T10:46:32","slug":"fischer-medical-ventures-reports-123-percent-yoy-surge-in-total-income-for-q2-fy26","status":"publish","type":"post","link":"https:\/\/dailynewsindia.co.in\/index.php\/2025\/10\/29\/fischer-medical-ventures-reports-123-percent-yoy-surge-in-total-income-for-q2-fy26\/","title":{"rendered":"Fischer Medical Ventures Reports 123 Percent YoY Surge in Total Income for Q2 FY26"},"content":{"rendered":"
\n

Mumbai (Maharashtra) [India], October 29:<\/strong> <\/span>Fischer Medical Ventures\u00a0Limited(FISCHER | 524743 | INE771F01041),\u00a0one of the leading companies engaged in the\u00a0business of\u00a0developing innovative, cost-effective medical imaging, advanced diagnostics and point-of-care diagnostic solutions, has announced its unaudited financial results for Q2\u00a0& H1\u00a0FY26.<\/p>\n

Key\u00a0Consolidated\u00a0Financial Highlights<\/strong><\/p>\n

Q2 FY26\u00a0Key\u00a0Financial Highlights<\/strong><\/p>\n

\u2022\u00a0Total Income of\u00a0\u20b9\u00a088.79 Cr, YoY growth of 122.64%<\/p>\n

\u2022\u00a0EBITDA of\u00a0\u20b9\u00a018.74 Cr, YoY growth of 2,511.72%<\/p>\n

\u2022\u00a0EBITDA Margin of 21.10%, YoY growth of 1,930 BPS<\/p>\n

\u2022\u00a0Net Profit of\u00a0\u20b9\u00a013.96 Cr, YoY growth of 4,659.63%<\/p>\n

\u2022\u00a0Net Profit Margin\u00a0(%) of 15.72%, YoY growth of 1,499 BPS<\/p>\n

\u2022\u00a0EPS of\u00a0\u20b9\u00a02.15, YoY growth of 4,200.00%<\/p>\n

H1\u00a0FY26 Key Financial Highlights<\/strong><\/p>\n

\u2022\u00a0Total Income of\u00a0\u20b9\u00a0119.70 Cr, YoY growth of 135.90%<\/p>\n

\u2022\u00a0EBITDA of\u00a0\u20b9\u00a030.46 Cr, YoY growth of 2,274.35%<\/p>\n

\u2022\u00a0EBITDA Margin of 25.45%, YoY growth of 2,292 BPS<\/p>\n

\u2022\u00a0Net Profit of\u00a0\u20b9\u00a018.97 Cr, YoY growth of 1,0664.64%<\/p>\n

\u2022\u00a0Net Profit Margin (%) of 15.85%, YoY growth of 1,550\u00a0BPS<\/p>\n

\u2022\u00a0EPS of\u00a0\u20b9\u00a02.87, YoY growth\u00a0of\u00a09,466.67%<\/p>\n

Commenting on the Results,\u00a0Mr. Ravindran Govindan, Chairman\u00a0of\u00a0Fischer Medical Ventures Limited,\u00a0said:\u00a0\u201cQ2 was a very strong quarter for Fischer, marking significant improvement across all operational and financial parameters. The steep rise in profitability reflects the scalability of our model, better product realization, and the growing acceptance of Fischer\u2019s technology across India and overseas markets.<\/p>\n

India\u2019s MedTech and diagnostic industry is expanding rapidly, driven by government focus on indigenous manufacturing, preventive care, and AI-led healthcare solutions. Fischer is well aligned with these trends, leveraging its expertise in MRI systems, AI diagnostics, and digital health platforms to strengthen its position in this evolving landscape.<\/p>\n

With our expanding footprint across Southeast Asia, new product launches, and advanced solutions such as\u00a0SpinCare\u00ae and portable X-ray systems, we are confident of sustaining this growth momentum and creating long-term value for all\u201d<\/p>\n

Key Business Highlights<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n
Acquires Strategic Property in Malaysia<\/td>\n\u2022\u00a0Acquired landmark mixed-use\u00a0property in\u00a0Malaysia\u00a0to\u00a0develop an Integrated Regional Healthcare Hub<\/p>\n

\u2022\u00a0Expand FMV\u2019s presence across Southeast Asia<\/p>\n<\/td>\n<\/tr>\n

Public\u2013Private Partnership in Indonesia<\/td>\n\u2022\u00a0Partnered City of Jember to deploy AI-powered portable X-ray systems<\/p>\n

\u2022\u00a0Supports \u201cTB\u00a0Free\u00a0Jember by 2026\u201d\u00a0&\u00a0TB elimination by 2030\u00a0projects\u00a0valued at\u00a0USD 10 million\u00a0(approx.)<\/p>\n<\/td>\n<\/tr>\n

Global Innovation Licensing Milestone<\/td>\n\u2022\u00a0Secures\u00a0full licensing in Indonesia, eligible to participate in End-TB Handheld X-ray Government Tender<\/td>\n<\/tr>\n
Diagnostic Imaging Expansion in India<\/td>\n\u2022\u00a0Launched High-Resolution Open MRI at Sunray Scans, Chennai<\/p>\n

\u2022\u00a0Installed PICA 0.35T Open MRI at STNM Hospital, Sikkim<\/p>\n<\/td>\n<\/tr>\n

AI Innovation Recognition \u2013 NYB.AI (JV Partner)<\/td>\n\u2022\u00a0Won 1st Prize at\u00a0SuperAI\u00a0Genesis Global Competition<\/p>\n

\u2022\u00a0Recognized for AI-driven drug discovery platform (DTIGN)<\/p>\n

\u2022\u00a0Partners include NVIDIA, J&J Innovation, and HPE<\/p>\n<\/td>\n<\/tr>\n

Nanomedic\u00a0\u2013 Operational & Regulatory Progress<\/td>\n\u2022\u00a0Completed Phase 1 MDR\/MDD audit; Phase 2 due Oct 2025<\/p>\n

\u2022\u00a0Preparing\u00a0SpinCare\u00ae FDA filing; outcome expected Q4 FY26<\/p>\n<\/td>\n<\/tr>\n

SpinCare- Clinical Advancements<\/td>\n\u2022\u00a0Proven safe and effective in\u00a0pediatric\u00a0burns<\/p>\n

\u2022\u00a0Stanford trial showed strong tolerability, no adverse events<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Mumbai (Maharashtra) [India], October 29: Fischer Medical Ventures\u00a0Limited(FISCHER | 524743 | INE771F01041),\u00a0one of the leading companies engaged in the\u00a0business of\u00a0developing innovative, cost-effective medical imaging, advanced diagnostics and point-of-care diagnostic solutions, has announced its unaudited financial results for Q2\u00a0& H1\u00a0FY26. Key\u00a0Consolidated\u00a0Financial Highlights Q2 FY26\u00a0Key\u00a0Financial Highlights \u2022\u00a0Total Income of\u00a0\u20b9\u00a088.79 Cr, YoY growth of 122.64% \u2022\u00a0EBITDA of\u00a0\u20b9\u00a018.74 Cr,…<\/p>\n

Read More “Fischer Medical Ventures Reports 123 Percent YoY Surge in Total Income for Q2 FY26”<\/span> »<\/a><\/p>\n","protected":false},"author":1,"featured_media":42853,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[54],"class_list":["post-42852","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-business"],"_links":{"self":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts\/42852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/comments?post=42852"}],"version-history":[{"count":0,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/posts\/42852\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/media\/42853"}],"wp:attachment":[{"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/media?parent=42852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/categories?post=42852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailynewsindia.co.in\/index.php\/wp-json\/wp\/v2\/tags?post=42852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}